UPDATE: Phibro Animal Health (PAHC) Tops Q2 EPS by 6c, Offers FY Guidance
(Updated - February 3, 2020 4:44 PM EST)
Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.34, $0.06 better than the analyst estimate of $0.28. Revenue for the quarter came in at $214 million versus the consensus estimate of $218.89 million.
Guidance:
Company sees FY20 EPS of $1.15-$1.22 vs $1.11 consensus on revenue of $812-$828 million vs $$838.1 million consensus.
For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.
